Cost-effectiveness analysis of routine 13-valent pneumococcal conjugate vaccinations in Chinese infants

References

• GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1459–544. doi:10.1016/S0140-6736(16)31012-1. PMID:27733281.
   PubMed Web of Science ®Google Scholar
• O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, Lee E, Mulholland K, Levine OS, Cherian T, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009;374:893–902. doi:10.1016/S0140-6736(09)61204-6. PMID:19748398.
   PubMed Web of Science ®Google Scholar
• Yao K-H, Yang Y-H. Streptococcus pneumoniae diseases in Chinese children: past, present and future. Vaccine. 2008;26:4425–33. doi:10.1016/j.vaccine.2008.06.052. PMID:18602435.
   PubMed Web of Science ®Google Scholar
• Ceyhan M, Ozsurekci Y, Aykac K, Hacibedel B, Ozbilgili E. Economic burden of pneumococcal infections in children under 5 years of age. Hum Vaccin Immunother. 2018;14:106–10. doi:10.1080/21645515.2017.1371378. PMID:28922054.
   PubMed Web of Science ®Google Scholar
• Nunes MC, Madhi SA. Review on the immunogenicity and safety of PCV-13 in infants and toddlers. Expert Rev Vaccines. 2011;10:951–80. doi:10.1586/erv.11.76. PMID:21806394.
   PubMed Web of Science ®Google Scholar
• Ben-Shimol S, Givon-Lavi N, Leibovitz E, Raiz S, Greenberg D, Dagan R. Near-elimination of otitis media caused by 13-valent pneumococcal conjugate vaccine (PCV) serotypes in southern Israel shortly after sequential introduction of 7-valent/13-valent PCV. Clin Infect Dis. 2014;59:1724–32. doi:10.1093/cid/ciu683. PMID:25159581.
   PubMed Web of Science ®Google Scholar
• Adegbola RA, DeAntonio R, Hill PC, Roca A, Usuf E, Hoet B, Greenwood BM. Carriage of Streptococcus pneumoniae and other respiratory bacterial pathogens in low and lower-middle income countries: a systematic review and meta-analysis. PLoS ONE. 2014;9:e103293. doi:10.1371/journal.pone.0103293. PMID:25084351.
   PubMed Web of Science ®Google Scholar
• Ruiz-Aragón J, Márquez Peláez S, Molina-Linde JM, Grande-Tejada AM. Safety and immunogenicity of 13-valent pneumococcal conjugate vaccine in infants: a meta-analysis. Vaccine. 2013;31:5349–58. doi:10.1016/j.vaccine.2013.09.008. PMID:24055349.
   PubMed Web of Science ®Google Scholar
• Shiri T, Datta S, Madan J, Tsertsvadze A, Royle P, Keeling MJ, McCarthy ND, Petrou S. Indirect effects of childhood pneumococcal conjugate vaccination on invasive pneumococcal disease: a systematic review and meta-analysis. Lancet Glob Health. 2017;5:e51–9. doi:10.1016/S2214-109X(16)30306-0. PMID:27955789.
   PubMed Web of Science ®Google Scholar
• Che D, Zhou H, He J, Wu B. Modeling the impact of the 7-valent pneumococcal conjugate vaccine in Chinese infants: an economic analysis of a compulsory vaccination. BMC Health Serv Res. 2014;14:56. doi:10.1186/1472-6963-14-56. PMID:24507480.
   PubMed Web of Science ®Google Scholar
• Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, Augustovski F, Briggs AH, Mauskopf J, Loder E, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)–explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. Value Health. 2013;16:231–50. doi:10.1016/j.jval.2013.02.002. PMID:23538175.
   PubMed Web of Science ®Google Scholar
• Wang X, Wang Z-F, Xie Y-M, Zhang W, Liao X, Chang Y-P. Specialty Committee of Evaluation of Postmarketing Chinese Medicines of World Federation of Chinese Medicine Societies. Guideline for postmarketing Chinese medicine pharmacoeconomic evaluation. Chin J Integr Med. 2015;21:473–80. doi:10.1007/s11655-014-1749-y. PMID:24671571.
   PubMed Web of Science ®Google Scholar
• Wijmenga-Monsuur AJ, van Westen E, Knol MJ, Jongerius RMC, Zancolli M, Goldblatt D, van Gageldonk PGM, Tcherniaeva I, Berbers GAM, Rots NY. Direct Comparison of Immunogenicity Induced by 10- or 13-Valent Pneumococcal Conjugate Vaccine around the 11-Month Booster in Dutch Infants. PLoS ONE. 2015;10:e0144739. doi:10.1371/journal.pone.0144739. PMID:26658902.
   PubMed Web of Science ®Google Scholar
• ZHENG J, CAI B, LI B, ZHANG F, YANG Z, QI Z, LEI Y, CHEN H. Hepatitis B Vaccine Coverage Rate and Influential Factors among Children in Hubei Province. Journal of Public Health and Preventive Medicine. 2005;16:4–6.
   Google Scholar
• Wu DB-C, Roberts C, Lee VWY, Hong L-W, Tan KK, Mak V, Lee KKC. Cost-effectiveness analysis of infant universal routine pneumococcal vaccination in Malaysia and Hong Kong. Hum Vaccin Immunother. 2016;12:403–16. doi:10.1080/21645515.2015.1067351. PMID:26451658.
   PubMed Web of Science ®Google Scholar
• Liu H, Xiao X, Lu J, Chen Z, Luo L, Yang Z. Study on epidemic characteristics and etiology of community acquired pneumonia in Guangzhou from 2009 to 2012. Zhonghua Yu Fang Yi Xue Za Zhi 2013;47:1089–94.
   PubMedGoogle Scholar
• Lee KKC, Rinaldi F, Chan MKU, Chan STH, So TMT, Hon EKL, Lee VWY. Economic evaluation of universal infant vaccination with 7vPCV in Hong Kong. Value Health. 2009;12(Suppl 3):S42–48. doi:10.1111/j.1524-4733.2009.00626.x. PMID:20586981.
   PubMedGoogle Scholar
• De Wals P, Black S, Borrow R, Pearce D. Modeling the impact of a new vaccine on pneumococcal and nontypable Haemophilus influenzae diseases: A new simulation model. Clin Ther. 2009;31:2152–69. doi:10.1016/j.clinthera.2009.10.014. PMID:19922887.
   PubMed Web of Science ®Google Scholar
• Monasta L, Ronfani L, Marchetti F, Montico M, Vecchi Brumatti L, Bavcar A, Grasso D, Barbiero C, Tamburlini G. Burden of disease caused by otitis media: systematic review and global estimates. PLoS ONE. 2012;7:e36226. doi:10.1371/journal.pone.0036226. PMID:22558393.
   PubMed Web of Science ®Google Scholar
• Wang J, Liu F, Ao P, Li X, Zheng H, Wu D, Zhang N, Yu J, Yuan J, Wu X. Detection of Serotype Distribution and Drug Resistance of Streptococcus Pneumoniae Isolated From Pediatric Patients. Lab Med. 2017;48:39–45. doi:10.1093/labmed/lmw059. PMID:28039377.
   PubMed Web of Science ®Google Scholar
• Huang S, Liu X, Lao W, Zeng S, Liang H, Zhong R, Dai X, Wu X, Li H, Yao Y. Serotype distribution and antibiotic resistance of Streptococcus pneumoniae isolates collected at a Chinese hospital from 2011 to 2013. BMC Infect Dis. 2015;15:312. doi:10.1186/s12879-015-1042-5. PMID:26243258.
   PubMed Web of Science ®Google Scholar
• Wang Q, Zhang F, Zhao C, Chen H, Wang Z, Guo Y, Li H, Wang H. [Antimicrobial resistance and serotype distribution of Streptococcus pneumoniae isolated from multi-centers across China, 2010 – 2011]. Zhonghua Jie He He Hu Xi Za Zhi. 2013;36:106–12. PMID:23537554.
   PubMedGoogle Scholar
• Delgleize E, Leeuwenkamp O, Theodorou E, Van de Velde N. Cost-effectiveness analysis of routine pneumococcal vaccination in the UK: a comparison of the PHiD-CV vaccine and the PCV-13 vaccine using a Markov model. BMJ Open. 2016;6:e010776. doi:10.1136/bmjopen-2015-010776. PMID:27903558.
   PubMed Web of Science ®Google Scholar
• Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen JR, Elvin L, Ensor KM, Hackell J, Siber G, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J. 2000;19:187–95. doi:10.1097/00006454-200003000-00003. PMID:10749457.
   PubMed Web of Science ®Google Scholar
• van Werkhoven CH. Herd effects of child vaccination with pneumococcal conjugate vaccine against pneumococcal non-invasive community-acquired pneumonia: What is the evidence? Hum Vaccin Immunother. 2017;13:1177–81. doi:10.1080/21645515.2016.1264548. PMID:27937061.
   PubMed Web of Science ®Google Scholar
• Xu B, Xu L, Cai H, Jiang L, Luo Y, Gu Y. The design of an m-Health monitoring system based on a cloud computing platform. ENTERPRISE INFORMATION SYSTEMS. 2017;11:17–36. doi:10.1080/17517575.2015.1053416.
   Web of Science ®Google Scholar
• Wen R, Deng Q, Sun C, Gao S, Tao J, Luo R. Pathogenic bacteria distribution and drug susceptibility in children with acute otitis media in Pearl River Delta. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2011;25:884–7. PMID:22242472.
   PubMedGoogle Scholar
• Bennett JE, Sumner W, Downs SM, Jaffe DM. Parents' utilities for outcomes of occult bacteremia. Arch Pediatr Adolesc Med. 2000;154:43–8. PMID:10632249.
   PubMedGoogle Scholar
• Oh PI, Maerov P, Pritchard D, Knowles SR, Einarson TR, Shear NH. A cost-utility analysis of second-line antibiotics in the treatment of acute otitis media in children. Clin Ther. 1996;18:160–82. doi:10.1016/S0149-2918(96)80188-3. PMID:8851461.
   PubMed Web of Science ®Google Scholar
• Knerer G, Ismaila A, Pearce D. Health and economic impact of PHiD-CV in Canada and the UK: A Markov modelling exercise. J Med Econ. 2012;15:61–76. doi:10.3111/13696998.2011.622323. PMID:22026590.
   PubMedGoogle Scholar
• Saokaew S, Rayanakorn A, Wu DB-C, Chaiyakunapruk N. Cost Effectiveness of Pneumococcal Vaccination in Children in Low- and Middle-Income Countries: A Systematic Review. Pharmacoeconomics. 2016;34:1211–25. doi:10.1007/s40273-016-0439-3. PMID:27510721.
   PubMed Web of Science ®Google Scholar
• Kulpeng W, Leelahavarong P, Rattanavipapong W, Sornsrivichai V, Baggett HC, Meeyai A, Punpanich W, Teerawattananon Y. Cost-utility analysis of 10- and 13-valent pneumococcal conjugate vaccines: protection at what price in the Thai context? Vaccine. 2013;31:2839–47. doi:10.1016/j.vaccine.2013.03.047. PMID:23588084.
   PubMed Web of Science ®Google Scholar
• Hou Z, Null Jie Chang, Yue D, Fang H, Meng Q, Zhang Y. Determinants of willingness to pay for self-paid vaccines in China. Vaccine. 2014;32:4471–7. doi:10.1016/j.vaccine.2014.06.047. PMID:24968160.
   PubMed Web of Science ®Google Scholar
• Maurer KA, Chen H-F, Wagner AL, Hegde ST, Patel T, Boulton ML, Hutton DW. Cost-effectiveness analysis of pneumococcal vaccination for infants in China. Vaccine. 2016;34:6343–9. doi:10.1016/j.vaccine.2016.10.051. PMID:27810315.
   PubMed Web of Science ®Google Scholar
• Mo X, Tobe RG, Liu X, Mori R. Cost-Effectiveness and Health Benefits of Pediatric 23-Valent Pneumococcal Polysaccharide Vaccine, 7-Valent and Forecasting 13-Valent Pneumococcal Conjugate Vaccines in China. Pediatr Infect Dis J. 2016;35:e353–61. doi:10.1097/INF.0000000000001288. PMID:27753771.
   PubMed Web of Science ®Google Scholar
• Kim YK, LaFon D, Nahm MH. Indirect Effects of Pneumococcal Conjugate Vaccines in National Immunization Programs for Children on Adult Pneumococcal Disease. Infect Chemother. 2016;48:257–66. doi:10.3947/ic.2016.48.4.257. PMID:28032483.
   PubMed Web of Science ®Google Scholar
• Zhao D, Gai Tobe R, Cui M, He J, Wu B. Cost-effectiveness of a 23-valent pneumococcal polysaccharide vaccine immunization programme for the elderly in Shanghai, China. Vaccine. 2016;34:6158–65. doi:10.1016/j.vaccine.2016.11.003. PMID:27838068.
   PubMed Web of Science ®Google Scholar
• Li Y, An Z, Yin D, Liu Y, Huang Z, Ma Y, Li H, Li Q, Wang H. Disease burden of community acquired pneumonia among children under 5 y old in China: A population based survey. Hum Vaccin Immunother. 2017;13:1681–7. doi:10.1080/21645515.2017.1304335. PMID:28414567.
   PubMed Web of Science ®Google Scholar
• Qu F, Weschler LB, Sun Y, Sundell J. High pneumonia lifetime-ever incidence in Beijing children compared with locations in other countries, and implications for national PCV and Hib vaccination. PLoS ONE. 2017;12:e0171438. doi:10.1371/journal.pone.0171438. PMID:28166256.
   PubMed Web of Science ®Google Scholar
• Wu DB-C, Chang C-J, Huang Y-C, Wen Y-W, Wu C-L, Fann CS-J. Cost-effectiveness analysis of pneumococcal conjugate vaccine in Taiwan: A transmission dynamic modeling approach. Value Health. 2012;15:S15–19. doi:10.1016/j.jval.2011.11.013. PMID:22265061.
   PubMed Web of Science ®Google Scholar
• Daana M, Rahav G, Hamdan A, Thalji A, Jaar F, Abdeen Z, Jaber H, Goral A, Huppert A, Raz M, et al. Measuring the effects of pneumococcal conjugate vaccine (PCV7) on Streptococcus pneumoniae carriage and antibiotic resistance: the Palestinian-Israeli Collaborative Research (PICR). Vaccine. 2015;33:1021–6. doi:10.1016/j.vaccine.2015.01.003. PMID:25593104.
   PubMed Web of Science ®Google Scholar